-+ 0.00%
-+ 0.00%
-+ 0.00%

GU Ventures attends Swiss Nordic Bio 2026 in Zurich

PUBT·10/06/2026 08:34:06
GU Ventures attends Swiss Nordic Bio 2026 in Zurich
  • GU Ventures visited Switzerland to build cross-border life science partnerships, including meetings in Basel and participation at Swiss Nordic Bio 2026.
  • Talks in Basel focused on collaboration models linking universities, industry, investors, and innovation hubs to support research commercialization.
  • Engagement centered on New Modality Support, targeting therapeutic oligonucleotides and ATMP projects for international development and market access.
  • Portfolio companies Serial X and Ondosis attended Swiss Nordic Bio 2026 alongside the delegation to expand investor and industry contacts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GU Ventures AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.